Universal Access to Antiretroviral Therapy: When, Not If

作者: C. C. J. Carpenter

DOI: 10.1086/499062

关键词:

摘要: The global HIV/AIDS pandemic poses the greatest health challenge in recent history. Effective large-scale treatment of several million infected individuals has appeared to present an almost insurmountable task. An ambitious approach this was developed by World Health Organization (WHO) "3 5" program 2003 with goal providing 3 affected low- and middle-income countries end 2005. Although immediate not been achieved 1500000 Africans are now receiving antiretroviral therapy (ART). This initial WHO initiative tremendous value shifting international emphasis from "if" "when" universal access can be achieved. additional thoughtful analysis essential elements effective worldwide scale-up ART presented Institute Medicine early (excerpt)

参考文章(7)
Kelley P, Curran J, Arya M, Knobler S, Pray L, Debas H, Scaling Up Treatment for the Global AIDS Pandemic: Challenges and Opportunities ,(2005)
Catherine Orrell, David R. Bangsberg, Motasim Badri, Robin Wood, Adherence is not a barrier to successful antiretroviral therapy in South Africa. AIDS. ,vol. 17, pp. 1369- 1375 ,(2003) , 10.1097/00002030-200306130-00011
Matthias Egger, Margaret May, Geneviève Chêne, Andrew N Phillips, Bruno Ledergerber, François Dabis, Dominique Costagliola, Antonella D'Arminio Monforte, Frank De Wolf, Peter Reiss, Jens D Lundgren, Amy C Justice, Schlomo Staszewski, Catherine Leport, Robert S Hogg, Caroline A Sabin, M John Gill, Bernd Salzberger, Jonathan AC Sterne, None, Prognosis of HIV-1-infected patients starting highly active antiretroviral therapy: a collaborative analysis of prospective studies. The Lancet. ,vol. 360, pp. 119- 129 ,(2002) , 10.1016/S0140-6736(02)09411-4
Christopher J Gill, Davidson H Hamer, Jonathon L Simon, Donald M Thea, Lora L Sabin, No room for complacency about adherence to antiretroviral therapy in sub-Saharan Africa. AIDS. ,vol. 19, pp. 1243- 1249 ,(2005) , 10.1097/01.AIDS.0000180094.04652.3B
Evan Wood, Robert S. Hogg, Benita Yip, P. Richard Harrigan, Michael V. O'Shaughnessy, Julio S.G. Montaner, Effect of Medication Adherence on Survival of HIV-Infected Adults Who Start Highly Active Antiretroviral Therapy When the CD4+ Cell Count Is 0.200 to 0.350 × 109 cells/L Annals of Internal Medicine. ,vol. 139, pp. 810- 816 ,(2003) , 10.7326/0003-4819-139-10-200311180-00008
Nagalingeswaran Kumarasamy, Suniti Solomon, Sreekanth K Chaguturu, Anish P Mahajan, Timothy P Flanigan, P Balakrishnan, Kenneth H Mayer, The safety, tolerability and effectiveness of generic antiretroviral drug regimens for HIV-infected patients in south India. AIDS. ,vol. 17, pp. 2267- 2269 ,(2003) , 10.1097/00002030-200310170-00019
L. A. Spacek, H. M. Shihab, M. R. Kamya, D. Mwesigire, A. Ronald, H. Mayanja, R. D. Moore, M. Bates, T. C. Quinn, Response to antiretroviral therapy in HIV-infected patients attending a public, urban clinic in Kampala, Uganda. Clinical Infectious Diseases. ,vol. 42, pp. 252- 259 ,(2006) , 10.1086/499044